ISEC HealthcareSGX:40T 61 ROA % is 7.79% as of Mar. 2026, which is 28% below its 10-year median of 10.87. GuruFocus rates SGX:40T with a GF Score™ of 61/100 and a GF Value™ of S$0.45 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 681 Healthcare Providers & Services companies, ISEC Healthcare ranks better than 85.9% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. ISEC Healthcare's annualizedNet Income for the quarter that ended in Mar. 2026 was S$11.35 Mil.
ISEC Healthcare's average Total Assets over the quarter that ended in Mar. 2026 was S$145.65 Mil. Therefore, ISEC Healthcare's annualized ROA % for the quarter that ended in Mar. 2026 was 7.79%.
The historical rank and industry rank for ISEC Healthcare's ROA % or its related term are showing as below:
SGX:40T'
s ROA % Range Over the Past 10 Years
Min: 5.73 Med: 10.87 Max: 12.65
Current: 9.87
During the past 13 years, ISEC Healthcare's highest ROA % was 12.65%. The lowest was 5.73%. And the median was 10.87%.
SGX:40T's ROA % is ranked better than 85.9% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 1.79
vs SGX:40T: 9.87
ISEC Healthcare (SGX:40T) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
ISEC Healthcare ROA % Related Terms
ISEC Healthcare ROA % Historical Data
* Premium members only.
The historical data trend for ISEC Healthcare's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, ISEC Healthcare's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ISEC Healthcare ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ISEC Healthcare's ROA % distribution charts can be found below:
* The bar in red indicates where ISEC Healthcare's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
ISEC Healthcare (SGX:40T) has a ROA % of 7.79% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on ISEC Healthcare and its competitors. This is 28% below median its historical median of 10.87. Over the past decade, ISEC Healthcare's ROA % has ranged from 5.73 to 12.65. According to the industry distribution chart, ISEC Healthcare ranks #96 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 14.1%.
Is ISEC Healthcare's ROA % too high?
ISEC Healthcare's current ROA % of 7.79% is 28% below median its 10-year median of 10.87. Over the past 10 years, this metric has ranged from a low of 5.73 to a high of 12.65. The Healthcare Providers & Services industry median ROA % is 1.79. ISEC Healthcare's value of 7.79% is 335.2% above this industry median. Based on the distribution chart, ISEC Healthcare ranks #96 out of 681 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, ISEC Healthcare has a GF Score™ of 61/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ISEC Healthcare's ROA % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, ISEC Healthcare ranks #96 out of 681 companies for ROA %. This places ISEC Healthcare in the top 14% of its industry — outperforming the majority of peers. The industry median ROA % is 1.79. ISEC Healthcare's value of 7.79% is 335.2% above this benchmark. Historically, ISEC Healthcare's own ROA % has ranged from 5.73 to 12.65 over the past decade. While the company's 10-year median is 10.87 vs. the industry median of 1.79, ISEC Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.79, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ISEC Healthcare's current ROA % of 7.79% is 335.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on ISEC Healthcare and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ISEC Healthcare's current ROA % is 7.79%, which is 28% below median its own 10-year median of 10.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ISEC Healthcare stock overvalued right now?
Based on GuruFocus' analysis, ISEC Healthcare (SGX:40T) is currently considered Significantly Undervalued. The stock's GF Value™ is S$0.45, compared to a current price of S$0.32 — trading 30% below its estimated fair value. The current ROA % is 7.79%, which is 28% below median its 10-year median of 10.87 and 335.2% above the Healthcare Providers & Services industry median of 1.79. ISEC Healthcare's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For ISEC Healthcare (SGX:40T), the current ROA % is 7.79% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ISEC Healthcare (SGX:40T) Overvalued in 2026?
Based on GuruFocus' analysis, ISEC Healthcare stock appears to be undervalued.
The current stock price of S$0.32 is trading 30% below its estimated GF Value™ of S$0.45.
GuruFocus considers ISEC Healthcare to be Significantly Undervalued.
Key valuation signals for SGX:40T:
ROA %: 7.79% (28% below median its 10-year median of 10.87)
GF Value™: S$0.45 vs. price of S$0.32 (30% below fair value)
Industry Position: 335.2% above the Healthcare Providers & Services median (#96 of 681)
No single metric tells the full story. See the SGX:40T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ISEC Healthcare Ltd principal activity of the Company is that of an investment holding company. It is regional provider of comprehensive medical eye care services with ambulatory surgical centres. The company has two reportable segment which are Specialised health services: provision of medical care, consultancy, treatment and surgery in the field of ophthalmology; and General health services: provision of general medical and procedural treatment services. The majority of revenue comes from Specialised health services segment. The company has presence in Singapore, Malaysia, and Myanmar. The company generates majority of revenue from Malaysia.
61GF Score
Get the complete analysis for SGX:40T
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:40T has been successfully added to your 
